The following abstracts represent the oral presentations given at IWWM-12 (Prague-2024), Session 13: BTK-Inhibitors in WM II
Session Chairs: Alessandra Tedeschi, Ranjana Advani
Pirtobrutinib in relapsed/refractory WM: Results from Bruin Study Palomba (USA)
Tirabrutinib in Symptomatic WM and Bing-Neel Syndrome (BNS) Sekiguchi (Japan)
Orelabrutinib in Relapsed/Refractory WM: Long-Term Follow-up Cao (China)
Prospective Study of Acalabrutinib and Rituximab in Symptomatic Anti-MAG mediated IgM peripheral neuropathy Sarosiek (USA)